Related Experiment Video
Updated: Mar 2, 2026
Isolation and Culture of Primary Endothelial Cells from Canine Arteries and Veins
Published on: November 18, 2016
Effects of combretastatin A-4 phosphate on canine normal and tumor tissue-derived endothelial cells
Yusuke Izumi1, Keisuke Aoshima2, Yuki Hoshino3
1Laboratory of Advanced Veterinary Medicine, Department of Veterinary Clinical Medicine, Hokkaido University, Sapporo, Japan.
Abstract:
Combretastatin A-4 phosphate (CA4P) selectively blocks tumor blood flow. However, the detailed mechanisms through which CA4P specifically affects tumor blood vessels are not well understood. Recent reports revealed that tumor tissue-derived endothelial cells (TECs) have various specific features in comparison with normal tissue-derived endothelial cells (NECs). Thus, abnormalities in TECs may be involved in the selective vascular blockade mechanism of CA4P. In this study, we evaluated the effects of CA4P on canine NECs and TECs using confocal microscopy. NECs exhibited different susceptibilities at subconfluence and at 100% confluence. In addition, inhibition of vascular endothelial cadherin (VE-cadherin) in NECs increased the sensitivity of the cells to CA4P. TECs seemed to be more susceptible to CA4P than NECs. The expression pattern of VE-cadherin in TECs was abnormal compared with that of NECs, suggesting that VE-cadherin may have functional abnormalities in these cells. Taken together, these results indicate that the tumor-vascular selectivity of CA4P may be related to VE-cadherin dysfunction in TECs.
Insights
Combretastatin A-4 phosphate (CA4P) targets tumor blood vessels. This study suggests CA4P
Area of Science:
- Vascular biology
- Cancer research
- Pharmacology
Background:
- Combretastatin A-4 phosphate (CA4P) selectively blocks tumor blood flow, but its precise mechanisms remain unclear.
- Tumor-derived endothelial cells (TECs) possess unique characteristics compared to normal tissue-derived endothelial cells (NECs).
- Abnormalities in TECs may contribute to CA4P's selective vascular effects.
Purpose of the Study:
- To investigate the differential effects of CA4P on canine NECs and TECs.
- To explore the role of vascular endothelial cadherin (VE-cadherin) in CA4P's tumor vascular selectivity.
Main Methods:
- Confocal microscopy was used to evaluate CA4P's effects on NECs and TECs.
- Differential susceptibility of NECs at varying confluency levels was assessed.
- The impact of VE-cadherin inhibition on NEC sensitivity to CA4P was examined.
Main Results:
- TECs demonstrated higher susceptibility to CA4P compared to NECs.
- VE-cadherin expression patterns were abnormal in TECs versus NECs.
- Inhibition of VE-cadherin in NECs enhanced their sensitivity to CA4P.
Conclusions:
- The tumor vascular selectivity of CA4P may be linked to VE-cadherin dysfunction in TECs.
- Abnormal VE-cadherin function in tumor endothelial cells could be a key factor in CA4P's efficacy.
